GANNET53 Patient Website: welcome
On this website patients and their relatives can find all relevant information on ovarian cancer and the research programme GANNET53 which is funded by the European Union. The aim of GANNET53 is to find an efficient new therapy for patients whose ovarian cancer has returned after primary therapy of the disease, and has become resistant to platinum-containing standard chemotherapy.
Ovarian cancer
General information, diagnosis, therapy, follow-up care, recurrence.
Clinical trials in general
Types of clinical trials, the four phases of a clinical trial, importance of clinical trials, importance of translational research, data safety.
EU project GANNET53
Project description, trial design, planned analysis, patient information.
More information
The EU project GANNET53 and its results.
Patients' advocacy
Support groups in Berlin, Linz and Vienna (Ovarcome).
What else can I do?
Diet and cancer, exercise.
Stay connected
Project lead and management, GANNET53 trial sites near you, German Ovarian Cancer Foundation.